Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,767 | 191 | 79.6% |
| Travel and Lodging | $1,003 | 4 | 16.8% |
| Education | $216.89 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,829 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $533.75 | 30 | $0 (2023) |
| Medtronic Vascular, Inc. | $407.16 | 9 | $0 (2019) |
| Amgen Inc. | $368.10 | 16 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $337.04 | 20 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $207.80 | 11 | $0 (2019) |
| PFIZER INC. | $178.11 | 15 | $0 (2019) |
| Gilead Sciences, Inc. | $143.62 | 1 | $0 (2020) |
| Chiesi USA, Inc. | $122.94 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $109.33 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.53 | 5 | Abbott Laboratories ($133.78) |
| 2023 | $194.31 | 6 | Abbott Laboratories ($116.74) |
| 2022 | $241.93 | 11 | Abbott Laboratories ($153.72) |
| 2021 | $158.72 | 4 | Abbott Laboratories ($138.21) |
| 2020 | $1,805 | 16 | Abbott Laboratories ($1,606) |
| 2019 | $1,148 | 35 | Abbott Laboratories ($494.50) |
| 2018 | $1,026 | 54 | Medtronic Vascular, Inc. ($272.25) |
| 2017 | $1,202 | 66 | AstraZeneca Pharmaceuticals LP ($231.95) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $128.31 | General |
| Category: Heart Failure | ||||||
| 08/07/2024 | United Therapeutics Corporation | ORENITRAM (Drug), REMODULIN | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 07/17/2024 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO, ORENITRAM | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 05/23/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Heart Failure | ||||||
| 04/24/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $31.34 | General |
| 10/24/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/23/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardiology | ||||||
| 10/09/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Heart Failure | ||||||
| 04/09/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $95.53 | General |
| Category: Heart Failure | ||||||
| 02/28/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Heart Failure and Hypertension | ||||||
| 02/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Heart Failure | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $58.00 | General |
| Category: Heart Failure | ||||||
| 07/06/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Cardiovascular | ||||||
| 05/24/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Heart Failure | ||||||
| 04/06/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Heart Failure | ||||||
| 04/06/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Heart Failure | ||||||
| 02/17/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Heart Failure | ||||||
| 07/02/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Heart Failure | ||||||
| 05/19/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Heart Failure | ||||||
| 04/29/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $98.99 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 786 | 932 | $111,630 | $39,258 |
| 2022 | 13 | 651 | 774 | $108,385 | $38,480 |
| 2021 | 14 | 929 | 1,060 | $108,479 | $40,727 |
| 2020 | 7 | 161 | 178 | $20,097 | $8,040 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 124 | $31,372 | $10,491 | 33.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 143 | 143 | $19,877 | $6,857 | 34.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 65 | $17,355 | $6,084 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $12,173 | $4,605 | 37.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 48 | $9,744 | $4,334 | 44.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 31 | $5,332 | $1,705 | 32.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 188 | 246 | $3,936 | $1,391 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,504 | $1,292 | 36.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $2,365 | $760.47 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 54 | 59 | $2,419 | $516.26 | 21.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 52 | 53 | $848.00 | $312.51 | 36.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 22 | 22 | $946.00 | $310.26 | 32.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 29 | 29 | $841.00 | $276.66 | 32.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 21 | 21 | $756.00 | $261.87 | 34.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 26 | 27 | $162.00 | $59.32 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 139 | $35,167 | $12,616 | 35.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 143 | 143 | $19,877 | $7,190 | 36.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 60 | 61 | $16,287 | $5,779 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $11,844 | $4,237 | 35.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 51 | $10,353 | $3,853 | 37.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 36 | $6,192 | $1,938 | 31.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 139 | 174 | $2,784 | $1,052 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,628 | $779.30 | 29.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 32 | 35 | $1,435 | $350.88 | 24.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 24 | 24 | $696.00 | $258.09 | 37.1% |
About Dr. Jonathan Buggey, MD
Dr. Jonathan Buggey, MD is a Cardiovascular Disease healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1013250133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Buggey, MD has received a total of $5,987 in payments from pharmaceutical and medical device companies, with $210.53 received in 2024. These payments were reported across 197 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,767).
As a Medicare-enrolled provider, Buggey has provided services to 2,527 Medicare beneficiaries, totaling 2,944 services with total Medicare billing of $126,504. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Akron, OH
- Active Since 03/27/2013
- Last Updated 06/10/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013250133
Products in Payments
- Ensite Cardiac Mapping System (Device) $1,410
- BRILINTA (Drug) $417.28
- CardioMEMS HF System (Device) $375.99
- HeartMate 3 Left Ventricular Dev (Device) $374.86
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $364.79
- ENTRESTO (Drug) $337.04
- Definity (Drug) $207.80
- Corlanor (Drug) $191.26
- Repatha (Biological) $176.84
- Contour 3D (Device) $118.12
- HeartMate 3 Left Ventricular Assist Device (Device) $117.27
- FARXIGA (Drug) $116.47
- XARELTO (Drug) $109.33
- Mosaic (Device) $106.44
- CHANTIX (Drug) $104.94
- NORTHERA (Drug) $99.26
- Avalus (Device) $98.48
- LifeVest (Device) $93.93
- HeartWare HVAD (Device) $84.12
- ELIQUIS (Drug) $73.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Akron
Joseph Pietrolungo, Do Fsvmb Facc, DO FSVMB FACC
Cardiovascular Disease — Payments: $164,248
Vinayak Hegde, Md, MD
Cardiovascular Disease — Payments: $131,332
Maher Bazzi, Md, MD
Cardiovascular Disease — Payments: $28,783
Dr. Kevin Silver, Md,Facc,Fscai,Fasnc, MD,FACC,FSCAI,FASNC
Cardiovascular Disease — Payments: $16,467
Anmar Kanaa'n, Md, MD
Cardiovascular Disease — Payments: $13,540
Dr. William Bauman, Md, MD
Cardiovascular Disease — Payments: $4,711